Abstract

Parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHRP) interact with a common G protein-coupled receptor and stimulate production of diverse second messengers (i.e. cAMP, diacylglycerol, and inositol 1,4,5-trisphosphate) that varies depending on the target cell. In renal proximal tubule OK cells, PTH inhibits the activity of the apical membrane Na+/H+ exchanger, although it is unclear whether the signal is transmitted through protein kinase A (PKA) and/or protein kinase C (PKC). To delineate the signaling circuitry, a series of synthetic PTH and PTHRP fragments were used that stimulate the adenylate cyclase-cAMP-PKA and/or phospholipase C-diacylglycerol-PKC pathways. Human PTH-(1-34) and PTHRP-(1-34) stimulated adenylate cyclase and PKC activity, whereas the PTH analogues, PTH-(3-34), PTH-(28-42), and PTH-(28-48), selectively enhanced only PKC activity. However, each peptide fragment inhibited Na+/H+ exchanger activity by 40-50%, suggesting that PKC and possibly PKA were capable of transducing the PTH/PTHRP signal to the transporter. This was corroborated when forskolin and phorbol 12-myristate 13-acetate (PMA), direct agonists of adenylate cyclase and PKC, respectively, both inhibited the Na+/H+ exchanger. The specific PKA antagonist, H-89, abolished the forskolin-mediated suppression of Na+/H+ exchanger activity, but did not prevent the inhibitory effects of PTH-(1-34) or PMA. In comparison, the potent PKC inhibitor, chelerythrine chloride, prevented the inhibition of Na+/H+ exchanger activity mediated by PTH-(28-48) and PMA but did not avert the negative regulation caused by PTH-(1-34) or forskolin. However, inhibition of both PKA and PKC prevented PTH-(1-34)-mediated suppression of Na+/H+ exchanger activity, indicating that PTH-(1-34) acted through both signaling pathways. In addition, Northern blot analysis revealed the presence of only the NHE-3 isoform of the Na+/H+ exchanger in OK cells. In summary, these results demonstrated that NHE-3 is expressed in OK cells and that activation of the PTH receptor can stimulate both the PKA and PKC pathways, each of which can independently lead to inhibition of NHE-3 activity.

Highlights

  • From the Departments of :j:Physiology and "IIMedicine, McGill University and the §Calcium Research Laboratory, Royal Victoria Hospital, Montreal, Quebec, Canada H3G lY6

  • To investigate the linkage of the Parathyroid hormone (PTH) receptor to these two signaling pathways in the opossum kidney (OK) cell line, experiments were conducted using a series of synthetic fragments of human PTH and parathyroid hormone-related peptide (PTHRP) that should allow one to distinguish between activation of the adenylate cyclase-cAMP-protein kinase A (PKA) and/or phospholipase C-DAG-protein kinase C (PKC)

  • In contrast to the effect on the adenylate cyclase system, hormone-stimulated translocation of PKC activity from cytosol to membrane was observed with all the fragments in a concentration-dependent manner (Ko.5 ~1O-11 M) except PTHRP-(1-16) which was inert in the PKC assay as it was in the adenylate cyclase assay

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 270, No 34, Issue of August 25, pp. 20004-20010, 1995 Printed in U.S.A. Parathyroid Hormone and Parathyroid Hormone-related Peptide Inhibit the Apical Na+/H+ Exchanger NHE-3 Isoform in Renal Cells (OK) via a Dual Signaling Cascade Involving Protein Kinase A and C*. It is quite possible that only one of these two pathways predominates in the PTH ~ Na+/H+ exchanger signaling cascade This has been observed in the SV-40 transformed murine renal cortical proximal tubule (MCT) cell line, where PTH, forskolin, and PMA inhibited the apical Na+/H+ exchanger [26]. In the present study, we wished to examine in greater detail the hypothesis that PTH or PTHRP inhibits the apical membrane Na+/H+ exchanger by both the PKA and PKC pathways in the OK cell model system This was accomplished as follows: (i) by using a series of synthetic peptide fragments of PTH and PTHRP that selectively activate adenylate cyclase and/or phospholipase C and (ii) by using other downstream activators (i.e. forskolin and PMA) and selective inhibitors of the PKA and PKC pathways. Our results demonstrated that only the NHE-3 isoform is expressed in OK cells and that PTH and PTHRP inhibit NHE-3 via two distinct signaling pathways that act independently of each other

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call